Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €100.00 Price Target at Deutsche Bank

Deutsche Bank set a €100.00 ($116.28) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Wednesday, July 31st, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other equities analysts also recently weighed in on FME. Kepler Capital Markets set a €80.00 ($93.02) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Thursday, May 2nd. Goldman Sachs Group set a €80.00 ($93.02) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, July 30th. UBS Group set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, July 30th. Berenberg Bank set a €89.95 ($104.59) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, July 26th. Finally, Independent Research set a €74.00 ($86.05) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Monday, June 17th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of €80.49 ($93.59).

ETR:FME traded up €0.32 ($0.37) during trading hours on Wednesday, hitting €60.60 ($70.47). 1,026,536 shares of the stock traded hands, compared to its average volume of 704,197. The company has a quick ratio of 0.63, a current ratio of 0.99 and a debt-to-equity ratio of 105.17. Fresenius Medical Care AG & Co. KGaA has a 1 year low of €55.44 ($64.47) and a 1 year high of €91.74 ($106.67). The company has a market cap of $18.50 billion and a price-to-earnings ratio of 15.03. The stock has a 50 day moving average price of €64.57 and a 200 day moving average price of €68.41.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: What is the definition of a trade war?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.